⚡ FDA Approves Pfizer COVID-19 Vaccine For Children Ages 5 To 11

The Food and Drug Administration has permitted Pfizer-BioNTech’s COVID-19 shot for kids ages 5 to 11, paving the best way for 28 million kids to get vaccinated within the U.S.

The federal company introduced its approval on an emergency use foundation on Friday. The Centers for Disease Control and Prevention’s vaccine advisory committee will subsequent meet to evaluate the FDA’s determination on Nov. 2-3. It’s anticipated to suggest it shortly after.

The FDA’s determination comes after an advisory panel for the company determined unanimously that the vaccine’s advantages for kids outweigh any potential dangers.

“Vaccinating younger children against COVID-19 will bring us closer to returning to a sense of normalcy,” mentioned performing FDA Commissioner Janet Woodcock in a press launch. “Our comprehensive and rigorous evaluation of the data pertaining to the vaccine’s safety and effectiveness should help assure parents and guardians that this vaccine meets our high standards.”

Pfizer’s vaccine had already been permitted for kids ages 12 to 15 on an emergency use foundation, an approval that was made in May.

Pfizer has mentioned that its smaller, pediatric-sized coronavirus vaccine is nearly 91% efficient at stopping symptomatic infections in 5- to 11-year-olds. The commonest unwanted effects reported had been fatigue, headache, muscle ache and chills, that are related unwanted effects documented in older kids and adults.

Pfizer’s vaccine requires two doses which might be administered three weeks aside. It then takes two weeks for full safety to kick in.

The White House has mentioned that it has bought sufficient doses, in addition to smaller, child-sized needles, to vaccinate all the nation’s 5- to 11-year-olds.

“The U.S. Department of Health and Human Services is working hand-in-hand with states to make this vaccine supply available in communities across the country as rapidly as possible,” the White House mentioned final week.

This is a growing story. Please verify again for updates.